The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

US Adds $38 Million for Ebola as CDC Warns Outbreak Could Match 2014

The United States said on Friday it would provide an additional $38 million for Ebola response efforts, as the CDC warned that without strong public health interventions the...

Whole Blood vs Components: No Survival Benefit in Trauma

Prehospital transfusion with whole blood was not linked to reduced 30-day mortality compared with prehospital transfusion with blood components in patients with traumatic hemorrhage, a phase 3 trial finds.

New POCUS for Residents: Should Hospitalists Join?

Few attending hospitalists have formal training in point-of-care ultrasound, but more are eager to learn.

Hospitalists Leading Health Informatics in the Digital Age

Technology in hospitals is changing quickly, having clinicians at the helm makes a difference.

Health Experts to Screen US Wastewater for Disease Outbreaks During World Cup

Epidemiologists will be busy this summer sifting through sewage and social media with the goal of keeping soccer fans and the public safe from severe illness during the...

'They're Betting Our Herd': Texas Ranchers Question USDA as Screwworm Returns

Like many ranchers in South Texas, Susan Storey said nightmarish screwworm outbreaks were among her first childhood memories. Now 62, she still recalls seeing wriggling...

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Latest News

The United States said on Friday it would provide an additional $38 million for Ebola response efforts, as the CDC warned that without strong public health interventions the...

Prehospital transfusion with whole blood was not linked to reduced 30-day mortality compared with prehospital transfusion with blood components in patients with traumatic hemorrhage, a phase 3 trial finds.

Few attending hospitalists have formal training in point-of-care ultrasound, but more are eager to learn.

Technology in hospitals is changing quickly, having clinicians at the helm makes a difference.

Epidemiologists will be busy this summer sifting through sewage and social media with the goal of keeping soccer fans and the public safe from severe illness during the...

Like many ranchers in South Texas, Susan Storey said nightmarish screwworm outbreaks were among her first childhood memories. Now 62, she still recalls seeing wriggling...

News All Time

Early Eosinophil Counts Affect Asthma in Pregnancy

Periconception levels show potential as a clinically useful marker for patients at risk.

MHRA Begins Review of Avacopan for Autoimmune Vasculitis

The UK’s drugs regulator is reviewing the integrity of trial data underpinning avacopan's licence for ANCA-associated vasculitis.

Ruto Says US Plan to Build Ebola Facility in Kenya Is the 'right Thing'

Kenyan President William Ruto on Thursday said his government was doing "the right thing" by allowing the United States to set up an Ebola quarantine facility ⁠in...

US Domestic Treatment Centers Ready for Ebola Even as Kenya Plans Persist

Most of the 13 U.S. treatment centers in a government-funded hospital network for severe infectious diseases are ready to handle patients, including those with Ebola if...

Otsuka Says Kidney Disease Drug Preserves Function in Late-stage Study

Otsuka Pharmaceutical said on Thursday its drug in a late-stage study preserved kidney ⁠function over 12 months in patients with a type of autoimmune disease that affects...

How Doctors’ Regrets Evolve — and What to Do With Yours

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Obexelimab Lowers Flare Risk in Phase 3 IgG4-RD Trial

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic steroid exposure in patients with active IgG4-related disease.

Anifrolumab Improves Multiple Sjögren Disease Measures

Early data from the ANISE-II study show that the lupus-approved treatment may also work well in managing Sjögren disease.

JAK1 Inhibitor Zemprocitinib Hits Targets in Refractory RA

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Infection Risk in Lupus and RA: What Matters Most

Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with new data highlighting where clinicians should focus.

Low‑Dose Egg Immunotherapy May Let Allergic Patients Eat Egg

Starting egg oral immunotherapy at low in-clinic doses and increasing them slowly is associated with better tolerance and may help patients with egg allergy reintroduce egg into their diets.

Tetrandrine Trialed as Novel Rheumatoid Arthritis Treatment

Chinese herb-derived compound tetrandrine shows signs of efficacy in methotrexate-treated patients with moderate to severe rheumatoid arthritis, but placebo rates are high.

Baricitinib Misses Key Safety Benchmark in High-Risk RA

Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Smoking May Lower Sjögren Disease Risk and Mask Pathology

Cigarette smokers have a significantly lower likelihood of being diagnosed with Sjögren's disease, with histologic data showing less tissue damage and lower disease activity in smokers who have it.

Anti-HLA Antibodies Linked to Fetal Growth Restriction

Anti-HLA antibody levels increased with the number of prior pregnancies and decreased with time since the last pregnancy, consistent with pregnancy-related alloimmunization.

JAK Inhibitors Not Tied to CVD Risk in Older Adults With AD

Oral JAKi are not associated with an increased short-term risk for major adverse cardiovascular events or venous thromboembolism in adults aged 50 years or older with atopic dermatitis.

Recommended News For You

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

More cancer cases in areas where incarceration rates are high: Study

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

Recommended Articles For You

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions 

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making 

Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder 

Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

2.

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

3.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Firefighters who eat better can combat cancer.

1.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

2.

Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma

3.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

4.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

5.

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

2.

Navigating the Complexities of Ph Negative ALL - Part V

3.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

4.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot